Clinical trial
A Trial of Exemestane in Postmenopausal Women With DCIS or at High Risk for Invasive Breast Cancer
NCT00073073 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial of Exemestane in Postmenopausal Women With DCIS or at High Risk for Invasive Breast Cancer
- Lead sponsor
- Georgetown University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- December 31, 2011
- Enrollment
- 46 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.